Press Releases

Year

Sep 2012

LifeVantage to Present at the Imperial Capital Global Opportunities Conference

SALT LAKE CITY , Sept. 13, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a company dedicated to helping people achieve healthy living through a combination of a compelling business opportunity and scientifically validated products, including its patented dietary supplement

PDF Version

Sep 2012

LifeVantage Corporation Receives Approval to List on the NASDAQ Capital Market

SALT LAKE CITY , Sept. 10, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), a company dedicated to helping people achieve healthy living through a combination of a compelling business opportunity and scientifically validated products, including its patented dietary supplement

PDF Version

Sep 2012

LifeVantage Announces Record Fourth Quarter and Full Fiscal Year 2012 Results

Company Receives Approval to List on The Nasdaq Capital Market Fourth Quarter Net Revenue Increases 197% Over Prior Year Period to $44.6 Million Fourth Quarter Operating Income Improves to a Record $7.3 Million Company Issues Full Year Fiscal 2013 Revenue, Operating Margin, and Earning Per Share

PDF Version

Aug 2012

LifeVantage to Announce Fiscal Fourth Quarter and Full Year 2012 Results on September 10, 2012

SALT LAKE CITY , Aug. 31, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), the leader in Nrf2 science and the maker of Protandim®, the Nrf2 Synergizer® patented dietary supplement, announced today it will release financial results for its fourth fiscal quarter and full year ended June

PDF Version

Aug 2012

LifeVantage Makes a Charitable Donation to Deworm the World

Through Its LifeVantage Legacy Program, Children in Bihar, India Receive Aid

PDF Version

Aug 2012

LifeVantage Corporation Completes Previously Announced CFO Transition

Company Appoints David Colbert as New Chief Financial Officer

PDF Version

Jul 2012

LifeVantage Corporation Makes a Charitable Donation to Hunger Relief International

Through Its LifeVantage Legacy Program, Orphans and Children in Need Receive Aid

PDF Version

Jun 2012

LifeVantage Announces Protandim(R) Subject of New Peer-Reviewed Article

Oxidative Medicine and Cellular Longevity Article Reports Protandim® Protects Human Coronary Artery Endothelial Cells Against Oxidative Challenge SALT LAKE CITY , June 27, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), the leader in Nrf2 science and the maker of Protandim®, the Nrf2

PDF Version

Jun 2012

LifeVantage to Present at the Accredited Members Summer 2012 Investment Conference

SALT LAKE CITY , June 7, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), the leader in Nrf2 science and the maker of Protandim ® , the Nrf2 Synergizer™ patented dietary supplement, announced today that Douglas C. Robinson , the Company's President and Chief Executive Officer, will be

PDF Version

Jun 2012

LifeVantage Corporation Expands Management Team to Further Strategic Corporate Objectives

SALT LAKE CITY , June 1, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), the leader in Nrf2 science and the maker of Protandim ® , the Nrf2 Synergizer® patented dietary supplement, announced today that it recently expanded its management team to continue to support the Company's

PDF Version

Pagination

First page
Previous page
…
Page 27
Page 28
Page 29
Page 30
Current page 31
Page 32
Page 33
Page 34
Page 35
…
Next page
Last page